Symptom evaluation cannot exclude retained gastric content in patients taking glucagon‐like peptide‐1 receptor agonists
Abstract
Symptom evaluation cannot exclude retained gastric content in patients taking glucagon-like peptide-1 receptor agonists
Fields of Study & Subjects
Diabetes Treatment and Management
Gastroesophageal reflux and treatments
Neuroendocrine Tumor Research Advances
Publication details
- Journal / source
- Anaesthesia
- Publisher
- Wiley
- Publication date
- 14 September 2026
- Language
- EN